Companies: 10,795·Total market cap: $144.5T
Naturally Splendid Enterprises Ltd.

Naturally Splendid Enterprises Ltd.

NSPDFOTCHealthcare● Active
$0.04
+$0.00(+0.00%)
Market Cap$881665
P/E Ratio
52W High$0.04
52W Low$0.000001

Naturally Splendid Enterprises Ltd. (NSPDF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

nspdf · pe ratio · data through Dec 31, 2021

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Naturally Splendid Enterprises Ltd. (NSPDF) measures how much investors pay for each dollar of the company's trailing earnings. NSPDF's current PE ratio of N/A is calculated by dividing its stock price of $0.04 by its TTM earnings per share of -$0.22.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2021-12-31

Forward P/E
N/A
EPS (TTM)
-$0.22
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Naturally Splendid Enterprises Ltd. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2012 – 2021 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Naturally Splendid Enterprises Ltd.
Naturally Splendid Enterprises Ltd.You
NSPDF
$1MN/A-$0.22
Acro Biomedical Co., Ltd.
Acro Biomedical Co., Ltd.
ACBM
$2MN/A-$0.00
Affymax, Inc.
Affymax, Inc.
AFFY
$0MN/A-$0.39
Amarantus BioScience Holdings, Inc.
Amarantus BioScience Holdings, Inc.
AMBS
$0MN/A-$0.01
ARYx Therapeutics, Inc.
ARYx Therapeutics, Inc.
ARYX
$0MN/A-$1.21
Baseline Productions, Inc.
Baseline Productions, Inc.
BSSP
$0MN/A-$0.01
CNBX Pharmaceuticals Inc.
CNBX Pharmaceuticals Inc.
CNBX
$0MN/A-$0.00

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 11 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2021-12-31Latest
FY2021
$-0.22
2020-12-31
FY2020
$-0.41
2019-12-31
FY2019
$-0.88
2018-12-31
FY2018
$-0.24
2017-12-31
FY2017
$-0.89
2016-12-31
FY2016
$-0.65
2015-12-31
FY2015
$-2.00
2014-12-31
FY2014
$-0.89
2013-12-31
FY2013
$-1.67
2013-01-31
FY2013
$-0.95

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Naturally Splendid Enterprises Ltd. (NSPDF) measures how much investors pay for each dollar of the company's trailing earnings. NSPDF's current PE ratio of N/A is calculated by dividing its stock price of $0.04 by its TTM earnings per share of -$0.22.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.04 ÷ -$0.22 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

NSPDF pe ratio · 6 questions

NSPDF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.04 and TTM EPS of -$0.22. Data sourced from Financial Modeling Prep via NSPDF's SEC 10-K and 10-Q filings.

NSPDF PE ratioWhat is NSPDF PE ratioCurrent PE ratio of NSPDFNSPDF PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Naturally Splendid Enterprises Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09